SCHEMBL6211528

SCHEMBL6211528

O=C(NCCCCC(=O)N1CCC2C1C(=O)CN2S(=O)(=O)Cc1cccnc1)c1ccc(N2CCOCC2)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
MAPT P10636 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
NAMPT P43490 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
HTR1A P08908 1/20 0.38
HTR2A P28223 1/20 0.38
DRD3 P35462 1/20 0.38
SMYD3 Q9H7B4 2/20 0.38
TP53 P04637 1/20 0.37
LMNA P02545 2/20 0.37
PTAFR P25105 2/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6210861 0.92 HDAC1 (0.41) ALDH1A1HDAC3HDAC1NAMPTHTR1A
SCHEMBL6259546 0.89 ALDH1A1 (0.46) ALDH1A1MAPTHDAC3HDAC1NAMPT
SCHEMBL6210118 0.89 DPP4 (0.44) ALDH1A1HDAC3HDAC1NAMPTSMN1; SMN2
SCHEMBL6211755 0.88 DPP4 (0.45) ALDH1A1NAMPTSMYD3LMNAPTAFR
SCHEMBL6211651 0.88 NAMPT (0.38) ALDH1A1MAPTNAMPTSMN1; SMN2SMYD3
SCHEMBL6211981 0.87 ALDH1A1 (0.46) ALDH1A1MAPTHDAC3HDAC1NAMPT
SCHEMBL6209329 0.87 HDAC3 (0.42) ALDH1A1HDAC3HDAC1NAMPTHTR1A
SCHEMBL6210722 0.87 CHRM4 (0.42) NAMPTPTAFR
SCHEMBL6215209 0.86 ROCK2 (0.40) ALDH1A1SMYD3LMNAPTAFR
SCHEMBL6211580 0.85 NAMPT (0.43) HDAC3HDAC1NAMPTSMYD3PTAFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP claimed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO claimed